[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581359":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":7,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"Royal Cornwall Hospitals Trust","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Verity Teague Research Sponsorship Facilitator","CONTACT","0044 1872256429","rcht.sponsor@nhs.net",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Royal Cornwall Hospital","RECRUITING","Truro","Cornwall","TR1 3HD","United Kingdom","UK",{"type":24,"coordinates":25},"Point",[26,27],-5.05436,50.26526,{"lat":27,"lon":26},[30],{"name":31,"role":11,"phone":32,"phoneExt":7,"email":13},"Verity Teague","01872256429",{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100581359","to-perform-a-post-market-study-of-the-performance-of-the-idylla-thyroidprint-assay-using-clinical-samples-in-predicting-the-nature-of-indeterminate-thyroid-nodules-itns-across-multiple-centers-100581359",false,"NCT06849284","To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.","Idylla™ ThyroidPrint® RUO Assay Beta-Trial Study","Inclusion Criteria:\n\n* Thyroid nodule ≥1.0 cm\n* With indeterminate cytology\n* Surgery due to be performed\n\nExclusion Criteria:\n\n* Specimens which fail to meet the inclusion criteria.\n* FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions.\n* RNA extracts.\n* Patients with ultrasound evidence of malignant cervical adenopathy","ALL","18 Years",{"count":45,"type":46},100,"ESTIMATED","OBSERVATIONAL","To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.",[50],"Thyroid Cancer","2025-05-29",{"date":53,"type":54},"2025-06-04","ACTUAL",{"date":56,"type":54},"2024-12-16",{"date":58,"type":46},"2025-06-30",{"name":5,"class":6},1]